electroCore Appoints Elena Bonfiglioli to Board of Directors

Core Insights - electroCore, Inc. has appointed Elena Bonfiglioli to its Board of Directors effective September 2, 2025, following the retirement of Peter Cuneo [1] - Ms. Bonfiglioli brings over two decades of experience in the healthcare sector, currently serving as Microsoft's Global Business Leader for Healthcare, Pharma Life Sciences, and International clinical applications [2] - She has been recognized as one of the top 50 AI Innovators and has held various leadership roles in healthcare organizations, emphasizing the use of data and AI to enhance health outcomes [2][3] Company Overview - electroCore, Inc. is a commercial-stage bioelectronic technology company focused on improving health and quality of life through non-invasive bioelectronic technologies [4] - The company's leading products include gammaCore, a non-invasive vagus nerve stimulation device, and Quell neurostimulator, both aimed at treating chronic pain syndromes [4] - Additionally, electroCore markets handheld products like Truvaga and TAC-STIM, which utilize bioelectronic technologies for general wellness and human performance [4]